#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mitochondrial DNA depletion Dupuytren's contracture Osteopetrosis Fatty acid oxidation disorder Philadelphia chromosome positive Multifocal motor neuropathy Plasma cell myeloma Systemic sclerosis pulmonary Hypoxic-ischaemic encephalopathy Bile acid synthesis disorder Scleroderma associated digital ulcer Juvenile psoriatic arthritis Demyelination Propionic acidaemia Immune-mediated enterocolitis More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Life with Disease Anaplastic thyroid cancer – Basic Information Chondrosarcoma – Trials in Disease Noonan syndrome – Basic Information Acute respiratory distress syndrome – Treatment Piriformis syndrome – Treatment Amyotrophic lateral sclerosis – Treatment Prader-Willi syndrome – Basic Information Gaucher’s disease type III – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sumatriptan Succinate Quavonlimab Rasburicase Taurine Gr0015 Florbetaben (18F) Alnuctamab Brexucabtagene Autoleucel SODIUM FUSIDATE Ecopipam Hydrochloride Interleukin-1 AZD0022 Morphine Hydrochloride PETHIDINE HYDROCHLORIDE Keto-Valine Calcium Azd5863 Siremadlin Mavorixafor Altizide SGN-ALPV More therapies…

    Learn about Your Condition

    Diabetic foot Urinary tract infection Alveolar proteinosis Alport's syndrome Myocardial infarction Pyelonephritis acute Oxygen therapy Kidney transplant rejection Hairy cell leukaemia recurrent Hip fracture Nodal osteoarthritis Cushing's syndrome Erythema migrans Osteoarthritis Bronchostenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Batoclimab for Treating Patients with Active Thyroid Eye Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Batoclimab
    Germany Italy Poland

  • Study on the Effectiveness and Safety of Atropine and DIMS Lenses for Myopia Control in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    Spain

  • Comparison of Atropine 0.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    The Netherlands

  • Study of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Dacarbazine
    • Darovasertib
    • Crizotinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on the Long-Term Safety of SAR422459 for Patients with Stargardt’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Investigated Drugs:
    • Lentiviral Vector Containing The Human Abca4 Gene
    France

  • Study on Adjuvant Treatment for Unilateral Retinoblastoma with Vincristine Sulfate and Drug Combination in Patients After Primary Eye Removal

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Cyclophosphamide
    • Thiotepa
    • Vincristine Sulfate
    France
Previous Page
1 … 21 22 23 24 25 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!